CPO
NVAX icon

Cerity Partners OCIO’s Novavax NVAX Stock Holding History

Cerity Partners OCIO’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,557
Closed -$234K – 439
2022
Q2 		$234K Buy
+4,557
New +$236K 0.01% 381
2022
Q1 		– Sell
-2,057
Closed -$294K – 443
2021
Q4 		$294K Sell
2,057
-44
-2% -$7.56K 0.01% 362
2021
Q3 		$436K Buy
+2,101
New +$463K 0.01% 320

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Cerity Partners OCIO's NVAX Position: Q3 2022 in Review

Cerity Partners OCIO sold out of Novavax (NVAX) in Q3 2022, closing a stake of 4,557 shares — an estimated $234K sold.

Cerity Partners OCIO first reported a position in NVAX in Q3 2021 and held it in 3 quarters. The position peaked at $436K in Q3 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Cerity Partners OCIO reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Cerity Partners OCIO sold 4,557 Novavax shares in Q3 2022, an estimated $234K.
  • Cerity Partners OCIO first reported a position in Novavax in Q3 2021 and held it in 3 quarters.
  • Cerity Partners OCIO's Novavax position peaked at $436K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Cerity Partners OCIO's 13F filing for Q3 2022, filed 20 Oct 2022.